With increasing information overload and packed work schedules, staying up-to-date on the newest oncologic advances is harder than ever. But take heart! The QuadShot is freshly brewed in your inbox four mornings each week so you can quickly down and digest the day's most pertinent cancer news.
ASCO has published new antiemetic guidelines to aid the administration of both chemo and radiation therapy. These recs center around four drugs: the 5-HT3 receptor antagonists like ondansetron, the NK1 receptor antagonists like aprepitant, the corticosteroid dexamethasone, and the antipsychotic (and new kid on the barf-block) olanzapine. They all can work, but some can get real pricey real fast. So what’s good on the $4 list, you ask? Easy. The P’s keep the Prices down: namely, Promethazine and Prednisone. And for those who aren’t into Poppin Pills, these guidelines also address non-pharmacologic therapies like medical marijuana, ginger, and acupuncture. So read up, because the only Ralph your patients flaunt should end in Lauren.